Expert opinion: Rescue me: Rescue medication for migraine

Headache

Volumn 50, Issue 2, 2010, Pages 307-313

  Whyte, Chad ^a   Tepper, Stewart J ^a   Evans, Randolph W ^b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANALGESIC AGENT; ANTIEMETIC AGENT; ANTIMIGRAINE AGENT; BACLOFEN; CORTICOSTEROID; DEXAMETHASONE; DICLOFENAC; DIHYDROERGOTAMINE; ERGOT DERIVATIVE; FLURBIPROFEN; IBUPROFEN; INDOMETACIN; KETOPROFEN; KETOROLAC; MAGNESIUM SULFATE; NAPROXEN; NAPROXEN PLUS SUMATRIPTAN; NEUROLEPTIC AGENT; NON PRESCRIPTION DRUG; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; PIRPROFEN; SUMATRIPTAN; TOLFENAMIC ACID; TOPIRAMATE; TRIPTAN DERIVATIVE; UNINDEXED DRUG; VALPROATE SEMISODIUM;

ADULT; AKATHISIA; CASE REPORT; CLINICAL PRACTICE; DIZZINESS; DROWSINESS; DRUG CONTRAINDICATION; DRUG COST; DRUG EFFICACY; DRUG INDICATION; DYSTONIA; EMERGENCY CARE; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HEADACHE; HUMAN; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; NOTE; OUTPATIENT CARE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RECOMMENDED DRUG DOSE; RECURRENT DISEASE; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ADULT; ANALGESIA; ANALGESICS; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIEMETICS; DRUG COMBINATIONS; DRUG RESISTANCE; FEMALE; HUMANS; MIGRAINE DISORDERS; TRYPTAMINES;

EID: 75849117796     PISSN: 00178748     EISSN: 15264610     Source Type: Journal    
DOI: 10.1111/j.1526-4610.2009.01597.x     Document Type: Note

References (52)

1. Diener HC, Limmroth V. Specific acute migraine treatment: Ergotamine and triptans. In: Lipton R, Bigal M, eds. Migraine and Other Headache Disorders: Tools and Rules for Diagnosis and Treatment. Hamilton, ON: BC Decker 2006: 289 310.
2. Evans RW. Treating migraine in the emergency department. BMJ. 2008 336: 1320.
3. Diamond S, Bigal ME, Silberstein S, Loder E, Reed M, Lipton RB. Patterns of diagnosis and acute and preventive treatment for migraine in the United States: Results from the American migraine prevalence and prevention study. Headache. 2007 47: 355 363.
4. Limmeroth V, Katsarava Z, Diener HC. Acetylsalicylic acid in the treatment of headache. Cephalalgia. 1999 19: 545 551.
5. Tfelt-Hansen P, Olesen J. Paracetamol (acetaminophen) versus acetylsalicylic acid in migraine. Eur Neurol. 1980 19: 163 165.
6. Boureau F, Joubert JM, Lasserre V, Prum B, Delecoeuilleire G. Double-blind comparison of an acetaminophen 400 mg-codeine 25 mg combination versus aspirin 1000 mg and placebo in an acute migraine attack. Cephalalgia. 1994 14: 156 161.
7. Tfelt-Hansen P, Olesen J. Effervescent metoclopramide and aspirin (Migravess) versus effervescent aspirin or placebo for migraine attacks: A double-blind study. Cephalalgia. 1984 4: 107 111.
8. Volans GN. The effect of metoclopramide on the absorption of effervescent aspirin in migraine. Br J Clin Pharmacol. 1975 2: 57 63.
9. Lipton RB, Baggish JS, Stewart WF, Codispoti JR, Fu M. Efficacy and safety of acetaminophen in the treatment of migraine: Results of a randomized, double-blind, placebo-controlled, population-based study. Arch Intern Med. 2000 160: 3486 3492.
10. Dexter SL, Graham AN, Johnston ES, Ratcliffe DM, Wilkinson MI, Rose AJ. Double-blind controlled study of paramax in the acute treatment of common and classical migraine. Br J Clin Pract. 1985 39: 388 392.
11. Myllylä VV, Havanka H, Herrala L, et al. Tolfenamic acid rapid release versus sumatriptan in the acute treatment of migraine: Comparable effect in a double-blind, randomized, controlled, parallel-group study. Headache. 1998 38: 201 207.
12. Nestvold K, Kloster R, Partinem M, Sulkava R. Treatment of acute migraine attack: Naproxen and placebo compared. Cephalalgia. 1985 5: 115 119.
13. Codispoti JR, Prior MJ, Fu M, Harte CM, Nelson EB. Efficacy of nonprescription doses of ibuprofen for treating migraine headache: A randomized controlled trial. Headache. 2001 41: 665 679.
14. Bussone G, Grazzi L, D'Amico D, et al. Acute treatment of migraine attacks: Efficacy and safety of a nonsteroidal anti-inflammatory drug, diclofenac potassium, in comparison to oral sumatriptan and placebo. The Diclofenac-K/Sumatriptan Migraine Study Group. Cephalalgia. 1999 19: 232 240.
15. Guidotti M, Zanasi S, Garagiola U. Pirprofen in the treatment of migraine and episodic headache attacks: A placebo-controlled crossover clinical trial. J Int Med Res. 1989 17: 48 54.
16. Solomon GD, Kunkel RS. Flurbiprofen in the prophylaxis of migraine. Cleve Clin J Med. 1993 60: 43 48.
17. Dib M, Massiou H, Weber M, Henry P, Garcia-Acosta S, Bousser MG Bi-Profenid Migraine Study Group. Efficacy of oral ketoprofen in acute migraine: A double-blind randomized clinical trial. Neurology. 2002 58: 1660 1665.
18. Nappi G, Micieli G, Tassorelli C, Viotti E, Altavilla T. Effectiveness of a piroxicam fast dissolving formulation sublingually administered in the symptomatic treatment of migraine without aura. Headache. 1993 33: 296 300.
19. Turkewitz LJ, Casaly JS, Dawson GA, Wirth O, Hurst RJ, Gillette PL. Self-administration of parenteral ketorolac tromethamine for head pain. Headache. 1992 32: 452 454.
20. Meredith JT, Wait S, Brewer KL. A prospective double-blind study of nasal sumatriptan versus ketorolac in migraine. Am J Emerg Med. 2003 21: 173 175.
21. Blumenthal HJ, Weisz MA, Kelly KM, Mayer RL, Blonski J. Treatment of primary headache in the emergency department. Headache. 2003 43: 1026 1031.
22. Tokola RA, Kangasneimi P, Neuvonen PJ, Tokola O. Tolfenamic acid, metoclopramide, caffeine, and their combinations in the treatment of migraine attacks. Cephalalgia. 1984 4: 253 263.
23. Friedman BW, Esses D, Solorzano C, et al. A randomized, controlled trial of prochlorperazine versus metoclopramide for treatment of acute migraine. Ann Emerg Med. 2008 52: 399 406.
24. Bigal ME, Bordini CA, Speciali JG. Intravenous chlorpromazine in the emergency room treatment department of migraines: A randomized controlled trial. J Emerg Med. 2002 23: 141 148.
25. Honkaniemi J, Liimatainen S, Rainesalo S, Sulavuori S. Haloperidol in the acute treatment of migraine: A randomized, double-blind, placebo-controlled study. Headache. 2006 46: 781 787.
26. Evans RW, Young WB. Droperidol and other neuroleptics/antiemetics for the management of migraine. Headache. 2003 43: 811 813.
27. Baldessarini RJ. Drugs and the treatment of psychiatric disorders: Psychosis and anxiety. In: Hardman JG, Limbird LE, Molinoff PB, et al, eds. Goodman and Gilman's the Pharmacological Basis of Therapeutics, 9th edn. New York: McGraw-Hill 1996: 399 430.
28. Gruppo LQ Jr. Intravenous Zofran for migraine. J Emerg Med. 2006 31: 228 229.
29. Colman I, Friedman BW, Brown MD, et al. Parenteral dexamethasone for acute severe migraine headache: Meta-analysis of randomised controlled trials for preventing recurrence. BMJ. 2008 336: 1359 1361.
30. Friedman BW, Greenwald P, Bania TC, et al. Randomized trial of IV dexamethasone for acute migraine in the emergency department. Neurology. 2007 69: 2038 2044.
31. Bigal ME, Bordini CA, Tepper SJ, Speciali JG. Intravenous magnesium sulphate in the acute treatment of migraine without aura and migraine with aura. A randomized, double-blind, placebo-controlled study. Cephalalgia. 2002 22: 345 353.
32. Corbo J, Esses D, Bijur PE, Iannaccone R, Gallagher EJ. Randomized clinical trial of intravenous magnesium sulfate as an adjunctive medication for emergency department treatment of migraine headache. Ann Emerg Med. 38: 621 627.
33. Reiter PD, Nickisch J, Merritt G. Efficacy and tolerability of intravenous valproic acid in acute adolescent migraine. Headache. 2005 45: 899 903.
34. Waberzinek G, Marková J, Mastík J. Safety and efficacy of intravenous sodium valproate in the treatment of acute migraine. Neuro Endocrinol Lett. 2007 28: 59 64.
35. Frazee LA, Foraker KC. Use of intravenous valproic acid for acute migraine. Ann Pharmacother. 2008 42: 403 407.
36. Loder E. Fixed drug combinations for the acute treatment of migraine. CNS Drugs. 2005 19: 769 784.
37. Lipton RB, Stewart WF, Ryan RE Jr., Saper J, Silberstein S, Sheftell F. Efficacy and safety of acetaminophen, aspirin, and caffeine in alleviating migraine headache pain: Three double-blind, randomized, placebo-controlled trials. Arch Neurol. 1998 55: 210 217.
38. Sandrini G, Cerbo R, Del Bene E, et al. Efficacy of dosing and re-dosing of two oral fixed combinations of indomethacin, prochlorperazine and caffeine compared with oral sumatriptan in the acute treatment of multiple migraine attacks: A double-blind, double-dummy, randomised, parallel group, multicentre study. Int J Clin Pract. 2007 61: 1256 1269.
39. Scher AI, Stewart WF, Lipton RB. Caffeine as a risk factor for chronic daily headache: A population-based study. Neurology. 2004 63: 2022 2027.
40. Bigal ME, Serrano D, Buse D, Scher A, Stewart WF, Lipton RB. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study. Headache. 2008 48: 1157 1168.
41. Silberstein SD, McCrory DC. Butalbital in the treatment of headache: History, pharmacology, and efficacy. Headache. 2001 41: 953 967.
42. McLean W, Boucher EA, Brennan M, et al. Is there an indication for the use of barbiturate-containing analgesic agents in the treatment of pain? Guidelines for their safe use and withdrawal management. Canadian Pharmacists Association. Can J Clin Pharmacol. 2000 7: 191 197.
43. Fraser HF, Wikier A, Essig CF, Isbell H. Degree of physical dependence induced by secobarbital or pentobarbital. JAMA. 1958 166: 126 129.
44. Loder E, Biondi D. Oral phenobarbital loading: A safe and effective method of withdrawing patients with headache from butalbital compounds. Headache. 2003 43: 904 909.
45. nd Annual Practicing Physician's Approach to the Difficult Headache Patient. February 9-13.2009. Abstract.
46. Storer RJ, Akerman S, Goadsby PJ. Characterization of opioid receptors that modulate nociceptive neurotransmission in the trigeminocervical complex. Br J Pharmacol. 2003 138: 317 324.
47. Jakubowski M, Levy D, Goor-Aryeh I, Collins B, Bajwa Z, Burstein R. Terminating migraine with allodynia and ongoing central sensitization using parenteral administration of COX1/COX2 inhibitors. Headache. 2005 45: 850 861.
48. Ho TW, Rodgers A, Bigal ME. Impact of recent prior opioid use on rizatriptan efficacy. A post hoc pooled analysis. Headache. 2009 49: 395 403.
49. Friedman BW, Kapoor A, Friedman MS, Hochberg ML, Rowe BH. The relative efficacy of meperidine for the treatment of acute migraine: A meta-analysis of randomized controlled trials. Ann Emerg Med. 2009 52: 705 713.
50. Tornabene SV, Deutsch R, Davis DP, Chan TC, Vilke GM. Evaluating the use and timing of opioids for the treatment of migraine headaches in the emergency department. J Emerg Med. 2009 36: 333 337.
51. Ashkenazi A, Levin M. Greater occipital nerve block for migraine and other headaches: Is it useful? Curr Pain Headache Rep. 2007 11: 231 235.
52. Hickling EJ, Silverman DJ, Loos W. A non-pharmacological treatment of vascular headache during pregnancy. Headache. 1990 30: 407 410.